Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q2 2024 Earnings Call Transcript August 6, 2024
Operator: Good afternoon. My name is Prila, and I’ll be your conference operator today. At this time, I would like to welcome everyone to the Halozyme Second Quarter 2024 Financial and Operating Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] Please note this...
